What changed in this filing

/stocks — the workspaceLOADING

Item 1A. Risk Factors

2025-05-15 compared with 2024-11-14 · 8 added, 57 removed, 5 unchanged (93% of the section changed)

In addition to the other information set forth

in this report, you should carefully consider the factors set forth below and discussed in the section entitled “Risk Factors”

in our 2023 Annual Report on Form 10-K, filed with the SEC, which are incorporated herein by reference.

The risks described in such

reports are not the only risks facing our Company.

Additional risks and uncertainties not currently known to us or that we currently deem

to be immaterial also may materially adversely affect our business, financial condition and/or operating results.

If we are unable to

maintain compliance with the listing requirements of The Nasdaq Capital Market, our common stock may be delisted from The Nasdaq Capital

Market which could have a material adverse effect on our financial condition and could make it more difficult for shareholders to sell

their shares.

Our common stock is listed

on The Nasdaq Capital Market, and we are therefore subject to its continued listing requirements, including requirements with respect

to the market value of publicly-held shares, market value of listed shares, minimum bid price per share, and minimum stockholder's equity,

among others, and requirements relating to board and committee independence.

If we fail to satisfy one or more of the requirements, we

may be delisted from The Nasdaq Capital Market.

On September 12, 2024, we received a letter from

the Staff of Nasdaq notifying us that for the previous 30 consecutive business days our common stock had not maintained a closing bid

price of $1.00 per share (the “Minimum Bid Price Requirement”) required for continued listing on The Nasdaq Capital Market

pursuant to Nasdaq Listing Rule 5550(a)(2).

Normally, a company would be afforded a 180-calendar day period to demonstrate compliance

with the Minimum Bid Price Requirement.

However, pursuant to Listing Rule 5810(c)(3)(A)(iv), we were not eligible for any compliance

period specified in Rule 5810(c)(3)(A) because we effected one or more reverse stock splits over the prior two-year period with a cumulative

ratio of 250 shares or more to one.

We requested a hearing before a Hearings Panel (the “Panel”), but prior to such hearing,

on October 30, 2024 the Panel provided us a temporary exception to regain compliance with the Minimum Bid Price Requirement until March

The Panel noted that it reserves the right to reconsider the terms of this exception based on any event, condition or circumstance

that exists or develops that would, in the opinion of the Panel, make continued listing of our securities on Nasdaq inadvisable or unwarranted.

The Panel notification advised us that the Nasdaq Listing and Hearing Review Council may, on its own motion, determine to review any Panel

decision within 45 calendar days after issuance of the written decision.

If the Listing Council determines to review the Panel’s

decision in our matter, it may affirm, modify, reverse, dismiss or remand the decision to the Panel.

We were previously not in compliance with the minimum

$2,500,000 stockholders’ equity requirement for continued listing set forth in Listing Rule 5550(b) (the “Equity Requirement”).

On September 10, 2024, we received a letter from the Nasdaq Office of General Counsel that we had demonstrated compliance with the Equity

Requirement and that the matter is closed.

According to the letter, pursuant to Nasdaq Listing Rule 5815(d)(4)(B), we are subject to a

Mandatory Panel Monitor for a period of one year from the date of the letter.

If, within that one-year monitoring period, the Staff finds

us again out of compliance with the Equity Requirement, notwithstanding Listing Rule 5810(c)(2), we will not be permitted to provide the

Staff with a plan of compliance with respect to that deficiency and Staff will not be permitted to grant additional time for us to regain

compliance with respect to that deficiency, nor will we be afforded an applicable cure or compliance period pursuant to Listing Rule 5810(c)(3).

Instead, Staff will issue a Delist Determination Letter and we will have an opportunity to request a new hearing with the initial Panel

or a newly convened Hearings Panel if the initial Panel is unavailable.

We will have the opportunity to respond/present to the Hearings

Panel as provided by Listing Rule 5815(d)(4)(C).

Our common stock may be at that time delisted from Nasdaq.

There can be no assurance

that we will continue to meet the continued listing requirements of The Nasdaq Capital Market and could be subject to delisting at a future

Delisting from The Nasdaq Capital Market would adversely affect our ability to raise additional financing through the public or

private sale of equity securities, may significantly affect the ability of investors to trade our securities and may negatively affect

the value and liquidity of our common stock.

Delisting also could have other negative results, including the potential loss of employee

confidence, the loss of institutional investors or interest in business development opportunities.

in this report, you should carefully consider the factors set forth in the section entitled “Risk Factors” in our 2024 Annual

Report on Form 10-K, filed with the SEC, which are incorporated herein by reference.

The risks described in such reports are not

the only risks facing our Company.

Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial

also may materially adversely affect our business, financial condition and/or operating results.

Unregistered Sales of Equity Securities and Use of Proceeds

Except as previously disclosed on Form 8-K, we

have not issued any unregistered securities during the quarter ended September 30, 2024.

We have not issued any unregistered securities

during the quarter ended March 31, 2025.

Defaults Upon Senior Securities

2 unchanged sentences

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-Q

Item 1A. Risk Factors